http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 12 Oct 2022 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Press+Releases/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html for the full story. http://www.streetinsider.com/Globe+Newswire/Entasis+Therapeutics%2C+a+Wholly+Owned+Subsidiary+of+Innoviva%2C+Announces+Data+on+SUL-DUR+to+be+Presented+at+IDWeek+2022/20692936.html Wed, 12 Oct 2022 08:30:00 -0400 A.03025382 A.07099426 A.13660633 A.38461071 ETTX INVA O.00025867 O.00164454 O.00391621 O.30696476 O.38887684 http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Entasis+Therapeutics+++++++++++++++++/20354413.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Entasis+Therapeutics+++++++++++++++++/20354413.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Entasis+Therapeutics+++++++++++++++++/20354413.html Thu, 21 Jul 2022 17:28:00 -0400 ETTX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Entasis+Therapeutics++++++For%3A+Jul+08++Filed+by%3A+Innoviva%2C+Inc./20323702.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Entasis+Therapeutics++++++For%3A+Jul+08++Filed+by%3A+Innoviva%2C+Inc./20323702.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Entasis+Therapeutics++++++For%3A+Jul+08++Filed+by%3A+Innoviva%2C+Inc./20323702.html Wed, 13 Jul 2022 21:28:00 -0400 ETTX http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Entasis+Therapeutics+++++++++++++++++/20319581.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Entasis+Therapeutics+++++++++++++++++/20319581.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Entasis+Therapeutics+++++++++++++++++/20319581.html Wed, 13 Jul 2022 06:03:00 -0400 ETTX